Exchange: NASDAQ·Updated 03:58 PM EDT

IMAB I-Mab - ADR

$1.62
$0.025
(1.57%)
Today
Reported EarningsAug 20
Mkt Cap$184.44M
Vol170,844.00

About IMAB

NovaBridge Biosciences operates as a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel or differentiated biologics to treat diseases with unmet medical needs, particularly cancers and autoimmune disorders. The company was founded by Jingwu Zang on June 30, 2016 and is headquartered in Rockville, MD.
50

Neutral Sentiment

How do you feel about IMAB?

Advertisement|Remove ads.